Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$208K Sell
5,375
-4,195
-44% -$160K ﹤0.01% 1374
2025
Q1
$371K Sell
9,570
-11,195
-54% -$410K ﹤0.01% 1358
2024
Q4
$702K Sell
20,765
-5,040
-20% -$181K 0.01% 1074
2024
Q3
$1.06M Sell
25,805
-8,133
-24% -$333K 0.01% 893
2024
Q2
$1.31M Buy
33,938
+3,310
+11% +$139K 0.01% 782
2024
Q1
$1.32M Sell
30,628
-1,390
-4% -$57.3K 0.01% 791
2023
Q4
$1.19M Buy
32,018
+3,736
+13% +$134K 0.01% 796
2023
Q3
$1.03M Sell
28,282
-2,044
-7% -$72.5K 0.01% 798
2023
Q2
$1.08M Sell
30,326
-284
-0.9% -$10.2K 0.01% 803
2023
Q1
$1.1M Buy
30,610
+8,905
+41% +$312K 0.02% 760
2022
Q4
$766K Sell
21,705
-9,076
-29% -$302K 0.01% 883
2022
Q3
$910K Buy
30,781
+6,887
+29% +$261K 0.02% 746
2022
Q2
$1.3M Sell
23,894
-5,824
-20% -$322K 0.02% 584
2022
Q1
$1.64M Buy
+29,718
New +$1.61M 0.03% 547

Other funds holding GSK